期刊文献+

马来酸依那普利和硝苯地平缓释片治疗2型糖尿病肾病合并蛋白尿和高血压的临床分析 被引量:1

Clinical analysis of enalapril maleate and nifedipine sustained-release tablets in the treatment of type 2 diabetic nephropathy with proteinuria and hypertension
下载PDF
导出
摘要 目的比较和分析血管紧张素转换酶(ACE)抑制剂(依那普利)和长效钙离子拮抗剂(硝苯地平缓释片)对2型糖尿病肾病(Diabetic nephropathy,DN)尿蛋白、高血压、及肾功能的治疗效果。方法将74例DN患者(男51例,女23例,平均年龄62±7岁)随机分为三组:马来酸依那普利组(27例)、硝苯地平缓释片组(24例)及两药联合治疗组(23例)。三组在严格控制血糖和饮食的基础上,分别服用依那普利5 mg、硝苯地平缓释片5 mg,清晨口服,每日1次,如果治疗2周后血压仍未降至正常(>140/90 mmHg),则马来酸依那普利、硝苯地平缓释片分别增加至10 mg,共用12周。结果两药单独治疗均可明显降低DN高血压(P<0.01),减少24小时尿白蛋白排出(P<0.05)。两药联合治疗降低血压和降低尿蛋白的幅度明显优于单独治疗(P<0.01)。结论马来酸依那普利和硝苯地平缓释片治疗DN所引起的高血压均有较好的降压作用,且能减少24小时尿蛋白的排泄,两药联合治疗疗效具有协同作用。 Objectice To Compare and analyze the treatment effect of angiotensin-converting enzyme (ACE) inhibitor (Enalapril maleate), and long-acting calcium antagonist (nifedipine sustained-release tablets) on the type 2 diabetic nephropathy proteinuria,hypertension, and renal function. Methods 74 cases DN patients (male 51 cases, female 23 cases, the average age of 62±7 years old) were randomly divided into three groups: Enatapril maleate group (27 cases), Nifedipine Sustained-release tablets group (24 cases)and the two drugs in the treatment group (23 cases). Three groups in the strict control of blood sugar and diet, enalapril maleate and nifedipine sustained-release tablets each were taking 5 mg,oral morning,once a day, after two weeks if the treatment had not yet returned to normal blood pressure (〉140/90 mmHg), enalapril maleate and nifedipine sustained-release tablets each increased to 10 mg,sharing 12 weeks. Results The treatment of the two drugs alone could significantly reduce the DN hypertension (P 〈 0.01) and the 24-hour urinary protein excretion (P 〈 0.05). Two drugs in the treatment of lower blood pressure and reduced the rate of urinary protein was better than treatment alone (P 〈 0.01). Conclusions Enalapril maleate and nifedipine sustained-release are better antihypertensive effect on hypertension caused by type 2 DN and can reduce the 24-hour urinary protein excretion. Two drugs in the treatment are synergies.
出处 《齐齐哈尔医学院学报》 2009年第16期1961-1963,共3页 Journal of Qiqihar Medical University
关键词 马来酸依那普利 硝苯地平缓释片 糖尿病肾病 高血压蛋白尿 Enalapril maleate Nifedipine sustained-release tablets Proteinuria HypertensiveDiabetic nephropathy
  • 相关文献

参考文献8

  • 1施曼珠.糖尿病肾病[J].中华肾脏病杂志,1993,9(5):297-299. 被引量:41
  • 2Parving HH, Rossing P. Calcium antagonists and the diabetic hypertensive patient[J]. Am J Kidney Dis, 1993,21 (6 Suppl 3) :47-52.
  • 3Laffel LM, McGrill B, Gans DJ. The beneficial effect of angiotensione onverting enzyme inhibition with captopril on diabetic nephropathy innormo -tensive IDDM Patients with microalbuminuia. North American Microalbuminuri a-study Group[J']. Am J Med,1995,99(5):497-504.
  • 4Charles Blais JR, Drapeall G, Raymondp, et al. contribution of ACE to car dial metabolism of brady Rinin, an interspecies study. Am J physiol,1997;273:2 263-2 271.
  • 5Nosadini R, Abaterusso C, Dalla Vestra M, et al, Efficacy of antihypertensive therapy in decreasing renal and cardiovascular complications in diabetes mellitus[J]. Nephrol Dial Transplant,1998,13 Suppl 8:44-8.
  • 6Bakris GL, Williams B. Angiotensin converting enzyme inhibitors and calcium antagonists alone or combined: does the progression of diabetic renal disease differ? [J]. J Hypertens Suppl, 1995,13(2) :S95-101.
  • 7Dworkin LD, Benstein JA, Parker M, et al. Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms[J]. Kidney Int, 1993,43(4) :808- 814.
  • 8AdersenS, Tamow L, Cambien F, et al. Renoprotective effects of Losartan in diabetic nephropathy;Interaction with ACE insertion/deletion genotype[J]. Kidney Int, 2002,62 ( 1 ) :192 - 198.

共引文献40

同被引文献9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部